Who
Donald H. Picker
Chief Science Officer
Company insider
Files Form 4 as: Chief Science Officer, Moleculin Biotech.
In numbers
- Trades disclosed
- 49
- Buys
- 1
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Oct 2017
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 | filing |
| 3 Aug 2026filed 5 Aug 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Bought | —173,333 | filing |
| 3 Aug 2026filed 5 Aug 2026 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code P | —519,999 | filing |
| 3 Aug 2026filed 5 Aug 2026 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code P | —519,999 | filing |
| 3 Aug 2026filed 5 Aug 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Bought | —173,333 | filing |
| 22 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code M | —71 | filing |
| 22 Jun 2026filed 24 Jun 2026 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code M | —71 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code F | $6621 at $3.12 | filing |
| 22 Jun 2026filed 24 Jun 2026 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code M | —71 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code M | —71 | filing |
| 22 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code F | $6621 at $3.12 | filing |
| 20 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code M | —44 | filing |
| 20 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code F | $3713 at $2.88 | filing |
| 20 Jun 2026filed 24 Jun 2026 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code M | —44 at $0.00 | filing |
| 20 Jun 2026filed 24 Jun 2026 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code M | —44 at $0.00 | filing |
| 20 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code M | —44 | filing |
| 20 Jun 2026filed 24 Jun 2026 | MBRX Moleculin BiotechBiotechnology | SEC FORM 4 Code F | $3713 at $2.88 | filing |
| 12 Nov 2025filed 14 Nov 2025 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 | filing |
| 12 Nov 2025filed 14 Nov 2025 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 | filing |
| 4 Nov 2025filed 6 Nov 2025 | MBRX Moleculin Biotechoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,750 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.